Clinical Trial Update: Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perifosine in patients with relapsed/refractory Waldenström's macroglobulinemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Waldenstrom's Macroglobulinemia | Phase 2 | Status: COMPLETED | Results posted: 2012-02-16